+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Custom Synthetic Genes Services Market by Technology (DNA Synthesis, Gene Construction, Gene Editing), Product (CRISPR Guide RNA, Gblocks, mRNA), End User, Application, Gene Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6085215
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The advent of synthetic gene services marks a transformative era in life sciences, where precision engineering of genetic constructs accelerates innovation across medicine, agriculture, and biotechnology. This report offers a panoramic view of the market’s evolution, delving into the convergence of advanced molecular techniques, regulatory shifts, and strategic partnerships that define the current landscape. It sets the stage for an informed understanding of how synthetic gene services have graduated from niche applications to foundational pillars supporting next-generation research and commercial ventures.

Transitioning from rudimentary cloning methods to sophisticated gene editing platforms, the industry has witnessed an unprecedented pace of technological breakthroughs. Stakeholders now navigate an ecosystem characterized by dynamic collaborations between academic institutions, technology providers, and end users across pharmaceutical, agricultural, and diagnostic sectors. This introduction frames the ensuing analysis, outlining the critical drivers and challenges that underpin market growth and establishing a framework for the deeper insights presented in subsequent sections.

Rapid Technological Breakthroughs and Collaborative Models Driving the Evolution of Synthetic Gene Services

The synthetic gene services industry has undergone rapid metamorphosis, fueled by breakthroughs in high-throughput DNA synthesis, precision editing tools, and bioinformatics integration. Machine learning algorithms now enable predictive design of gene constructs, while modular synthesis platforms dramatically shorten development cycles. Coupled with the rise of automation in liquid handling and synthesis workflows, these technological gains have democratized access to custom genes, reducing barriers for small and large players alike.

In parallel, strategic alliances between reagent suppliers, instrument manufacturers, and service labs have reshaped competitive dynamics. Co-development agreements and consortium-driven initiatives now address complex challenges such as error-free synthesis of long sequences and scalable purification. Regulatory agencies are adapting guidelines to accommodate novel techniques, fostering a more predictable environment for innovation. Consequently, the market has shifted toward collaborative, open-innovation models that transcend traditional vendor-client relationships.

Assessing the Multilayered Effects of 2025 US Tariff Revisions on Supply Chains, Costs, and Resilience

With the implementation of revised tariff schedules in 2025, synthetic gene service providers have recalibrated global supply chains to absorb new cost pressures on critical reagents and equipment. Import duties on specialized enzymes and synthesis platforms have elevated procurement expenses, prompting companies to reassess sourcing strategies. Many have shifted toward regional suppliers or established localized manufacturing hubs to mitigate the impact of cross-border levies and minimize lead times.

These adjustments have also accelerated opportunities for domestic innovation, as research institutions and contract service organizations invest in in-country capabilities to circumvent tariff-related disruptions. While initial capital outlays have increased, the long-term benefits include enhanced supply chain resilience and decreased dependency on distant vendors. Strategic pricing models have emerged, balancing margin preservation with competitive positioning, guaranteeing that end users continue to access advanced gene services without compromising on quality or delivery timelines.

Deep Dive into Multidimensional Market Segmentation Revealing Key Drivers and Innovation Pathways

In dissecting the synthetic gene services market through technological lenses, DNA synthesis emerges as a cornerstone, encompassing both de novo gene synthesis and high-fidelity oligonucleotide services. Complementing this are gene construction techniques such as recombinant cloning and restriction cloning, each addressing distinct research needs. Within gene editing, CRISPR Cas9 has spearheaded genome engineering, while TALEN and zinc finger platforms offer alternative precision modalities.

Product segmentation further illuminates demand patterns, spanning CRISPR guide RNA reagents, synthetic gene fragments like Gblocks, in vitro transcribed mRNA constructs, custom oligonucleotide synthesis, and plasmid DNA vectors. End users range from academic institutions driving fundamental discovery to biotech companies scaling translational pipelines, while contract research organizations and pharmaceutical enterprises leverage synthetic gene services to expedite drug development. Application areas traverse agriculture, where trait enhancement is paramount, to diagnostics that depend on rapid assay development, fundamental research probing gene function, and therapeutic modalities targeting complex disorders.

Finally, gene type categorization underscores the diversity of offerings: guide RNA species designed for targeted cleavage, mRNA constructs enabling transient expression, plasmid vectors as durable delivery systems, and viral vectors for in vivo applications. These intersecting segmentation dimensions highlight the intricate tapestry of demand drivers and innovation vectors within the market.

Comparative Regional Dynamics Exposing Growth Drivers and Investment Trends across Global Markets

Regional analysis reveals distinct demand drivers and investment climates across global markets. In the Americas, robust funding for gene therapy trials and a dense concentration of biotech hubs underpin sustained growth. Leading universities and research centers act as innovation catalysts, fostering an ecosystem where service providers rapidly iterate novel constructs to meet academic and commercial R&D needs.

Europe, the Middle East, and Africa present a heterogeneous landscape, characterized by stringent regulatory frameworks in parts of Western Europe and emerging genomics initiatives in the Gulf region. Collaborative networks and public-private partnerships have gained traction, enabling technology transfer and capacity building. This regional mosaic demands adaptive strategies that account for variable policy environments and infrastructure maturity.

Asia-Pacific is distinguished by aggressive investment in biotechnology infrastructure, with government-backed programs driving adoption of synthetic gene technologies. Platforms for local manufacturing of reagents and instruments are expanding, reducing reliance on imports and catalyzing rapid service delivery. As a result, this region is emerging as both a consumption market and a production powerhouse, reshaping global supply dynamics.

Strategic Positioning and Competitive Intelligence Highlighting Pioneers and Disruptors in the Synthetic Gene Sector

The competitive landscape is defined by a spectrum of entities ranging from established life science tool firms to specialized custom gene service providers and agile biotech startups. Leading reagent manufacturers continually expand their service portfolios, integrating automation and high-throughput capabilities to deliver seamless end-to-end solutions. Conversely, niche providers differentiate through ultra-precise synthesis of challenging sequences and bespoke editing services tailored to complex research queries.

Emerging players are forging strategic alliances with academic and clinical partners to co-develop next-generation platforms, while incumbent instrument companies are enhancing digital connectivity, enabling remote monitoring and real-time quality assurance. Mergers and acquisitions remain a critical avenue for consolidation, as organizations seek to broaden their technological footprints and secure access to proprietary delivery systems. This dynamic competitive milieu underscores the importance of strategic positioning and continuous innovation for market leadership.

Actionable Strategic Roadmap for Building Resilience and Driving Sustained Growth in Synthetic Gene Services

Industry leaders should prioritize building resilient, localized manufacturing capabilities that insulate against geopolitical and tariff-related uncertainties. Investing in modular synthesis platforms and flexible capacity expansions will enable rapid scaling in response to fluctuating demand. Simultaneously, deepening partnerships with academic institutions and contract research organizations can unlock co-development opportunities and accelerate time to market for novel applications.

Another imperative is to integrate advanced data analytics and predictive modeling into workflow pipelines, enhancing yield optimization and minimizing synthesis errors. Engaging proactively with regulatory bodies to shape emerging guidelines will foster a more conducive innovation environment. Finally, expanding presence in underserved regions through targeted collaborations and capacity-building initiatives can unlock new revenue streams while reinforcing global market resilience.

Robust Multimethod Research Framework Combining Primary Interviews and Secondary Data for Unmatched Market Clarity

The research methodology integrates primary and secondary data sources to ensure robust, multifaceted market intelligence. Primary insights were gathered through in-depth interviews with senior executives, service lab directors, and end users across academic, biotech, and pharmaceutical sectors. These discussions illuminated operational challenges, technology adoption drivers, and future investment priorities.

Complementing this, a comprehensive review of patent filings, regulatory filings, and peer-reviewed literature provided contextual understanding of technological trajectories. Quantitative data were sourced from industry databases, company disclosures, and import-export records to map supply chain flows and market activity. Data triangulation techniques validated trends, while scenario planning exercises tested the resilience of strategic imperatives under varying regulatory and economic conditions.

Synthesis of Key Insights Emphasizing Strategic Imperatives to Navigate the Dynamic Synthetic Gene Landscape

This executive summary synthesizes critical insights into the evolving synthetic gene services market, highlighting the interplay of technological innovation, regulatory dynamics, and shifting supply chain geographies. The analysis underscores how advanced synthesis and editing platforms, coupled with strategic collaborations, are accelerating discovery pipelines and opening new application frontiers.

Tariff adjustments and regional policy initiatives have prompted a reevaluation of sourcing strategies, driving localization efforts and partnership models that enhance resilience. Multidimensional segmentation reveals nuanced demand patterns, guiding stakeholders to tailor offerings across technology, product, end user, application, and gene type dimensions. Ultimately, the strategic recommendations outlined herein provide a clear roadmap for organizations to navigate this rapidly advancing landscape and secure competitive advantage.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Technology
    • DNA Synthesis
      • De Novo Gene Synthesis
      • Oligonucleotide Services
    • Gene Construction
      • Recombinant Cloning
      • Restriction Cloning
    • Gene Editing
      • CRISPR Cas9
      • TALEN
      • Zinc Finger
  • Product
    • CRISPR Guide RNA
    • Gblocks
    • mRNA
    • Oligonucleotide Synthesis
    • Plasmid DNA
  • End User
    • Academic Institutions
    • Biotech Companies
    • Contract Research Organizations
    • Pharmaceutical Companies
  • Application
    • Agriculture
    • Diagnostics
    • Research
    • Therapeutics
  • Gene Type
    • Guide RNA
    • mRNA
    • Plasmid Vectors
    • Viral Vectors
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Integrated DNA Technologies, Inc.
  • GenScript Biotech Corporation
  • Twist Bioscience Corporation
  • Agilent Technologies, Inc.
  • Eurofins Scientific SE
  • ATUM, Inc.
  • Bio Basic, Inc.
  • BGI Genomics Co., Ltd.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of CRISPR-based high-throughput editing techniques accelerates custom synthetic gene design
5.2. Adoption of AI-driven genomic sequence optimization enhances yield and reduces off-target effects in custom gene services
5.3. Expansion of cloud-based bioinformatics platforms for collaborative design and delivery of synthetic gene constructs
5.4. Rising demand for GMP-compliant synthetic genes fuels expansion of contract development and manufacturing organizations
5.5. Adoption of standardized DNA assembly kits and modular vector libraries streamlines custom gene synthesis workflows
5.6. Emphasis on sustainable and low-cost enzymatic synthesis methods minimizes environmental impact in gene fabrication processes
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Custom Synthetic Genes Services Market, by Technology
8.1. Introduction
8.2. DNA Synthesis
8.2.1. De Novo Gene Synthesis
8.2.2. Oligonucleotide Services
8.3. Gene Construction
8.3.1. Recombinant Cloning
8.3.2. Restriction Cloning
8.4. Gene Editing
8.4.1. CRISPR Cas9
8.4.2. TALEN
8.4.3. Zinc Finger
9. Custom Synthetic Genes Services Market, by Product
9.1. Introduction
9.2. CRISPR Guide RNA
9.3. Gblocks
9.4. MRNA
9.5. Oligonucleotide Synthesis
9.6. Plasmid DNA
10. Custom Synthetic Genes Services Market, by End User
10.1. Introduction
10.2. Academic Institutions
10.3. Biotech Companies
10.4. Contract Research Organizations
10.5. Pharmaceutical Companies
11. Custom Synthetic Genes Services Market, by Application
11.1. Introduction
11.2. Agriculture
11.3. Diagnostics
11.4. Research
11.5. Therapeutics
12. Custom Synthetic Genes Services Market, by Gene Type
12.1. Introduction
12.2. Guide RNA
12.3. MRNA
12.4. Plasmid Vectors
12.5. Viral Vectors
13. Americas Custom Synthetic Genes Services Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Custom Synthetic Genes Services Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Custom Synthetic Genes Services Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Merck KGaA
16.3.3. Integrated DNA Technologies, Inc.
16.3.4. GenScript Biotech Corporation
16.3.5. Twist Bioscience Corporation
16.3.6. Agilent Technologies, Inc.
16.3.7. Eurofins Scientific SE
16.3.8. ATUM, Inc.
16.3.9. Bio Basic, Inc.
16.3.10. BGI Genomics Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CUSTOM SYNTHETIC GENES SERVICES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CUSTOM SYNTHETIC GENES SERVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CUSTOM SYNTHETIC GENES SERVICES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. CUSTOM SYNTHETIC GENES SERVICES MARKET: RESEARCHAI
FIGURE 26. CUSTOM SYNTHETIC GENES SERVICES MARKET: RESEARCHSTATISTICS
FIGURE 27. CUSTOM SYNTHETIC GENES SERVICES MARKET: RESEARCHCONTACTS
FIGURE 28. CUSTOM SYNTHETIC GENES SERVICES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CUSTOM SYNTHETIC GENES SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DE NOVO GENE SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DE NOVO GENE SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY OLIGONUCLEOTIDE SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY OLIGONUCLEOTIDE SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RECOMBINANT CLONING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RECOMBINANT CLONING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RESTRICTION CLONING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RESTRICTION CLONING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CRISPR CAS9, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CRISPR CAS9, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TALEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TALEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ZINC FINGER, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ZINC FINGER, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CRISPR GUIDE RNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CRISPR GUIDE RNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GBLOCKS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GBLOCKS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY MRNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY MRNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PLASMID DNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PLASMID DNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY AGRICULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GUIDE RNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GUIDE RNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY MRNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY MRNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PLASMID VECTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PLASMID VECTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 115. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 116. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 117. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 118. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 119. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2024 (USD MILLION)
TABLE 120. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2025-2030 (USD MILLION)
TABLE 121. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 122. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 123. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 124. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 125. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2024 (USD MILLION)
TABLE 130. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2025-2030 (USD MILLION)
TABLE 131. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 132. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 133. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 134. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 135. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2024 (USD MILLION)
TABLE 136. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2025-2030 (USD MILLION)
TABLE 137. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 138. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 139. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 140. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 141. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2024 (USD MILLION)
TABLE 146. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2025-2030 (USD MILLION)
TABLE 213. GERMANY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 214. GERMANY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 215. GERMANY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 216. GERMANY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 217. GERMANY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2024 (USD MILLION)
TABLE 218. GERMANY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2025-2030 (USD MILLION)
TABLE 219. GERMANY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 220. GERMANY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 221. GERMANY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 222. GERMANY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 223. GERMANY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. GERMANY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. GERMANY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. GERMANY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. GERMANY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2024 (USD MILLION)
TABLE 228. GERMANY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2025-2030 (USD MILLION)
TABLE 229. FRANCE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 230. FRANCE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 231. FRANCE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 232. FRANCE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 233. FRANCE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2024 (USD MILLION)
TABLE 234. FRANCE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2025-2030 (USD MILLION)
TABLE 235. FRANCE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 236. FRANCE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 237. FRANCE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 238. FRANCE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 239. FRANCE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. FRANCE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. FRANCE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. FRANCE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. FRANCE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2024 (USD MILLION)
TABLE 244. FRANCE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2025-2030 (USD MILLION)
TABLE 261. ITALY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 262. ITALY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 263. ITALY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 264. ITALY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 265. ITALY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2024 (USD MILLION)
TABLE 266. ITALY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2025-2030 (USD MILLION)
TABLE 267. ITALY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 268. ITALY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 269. ITALY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 270. ITALY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 271. ITALY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. ITALY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. ITALY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 274. ITALY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 275. ITALY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2024 (USD MILLION)
TABLE 276. ITALY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2025-2030 (USD MILLION)
TABLE 277. SPAIN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 278. SPAIN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 279. SPAIN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 280. SPAIN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 281. SPAIN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2024 (USD MILLION)
TABLE 282. SPAIN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2025-2030 (USD MILLION)
TABLE 283. SPAIN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 284. SPAIN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 285. SPAIN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 286. SPAIN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 287. SPAIN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. SPAIN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. SPAIN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 290. SPAIN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 291. SPAIN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2024 (USD MILLION)
TABLE 292. SPAIN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES CUSTOM SYNTHETIC GENES SERVICES MARKET

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Custom Synthetic Genes Services market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Integrated DNA Technologies, Inc.
  • GenScript Biotech Corporation
  • Twist Bioscience Corporation
  • Agilent Technologies, Inc.
  • Eurofins Scientific SE
  • ATUM, Inc.
  • Bio Basic, Inc.
  • BGI Genomics Co., Ltd.